HTGMQ (HTG Molecular Diagnostics) Shares Outstanding (EOP): 2.21 Mil (As of Mar. 2023)


HTGMQ HTG Molecular Diagnostics Inc HTGMQ
12 GF Score
Price $0.00
View Full Analysis

What is HTG Molecular Diagnostics Shares Outstanding (EOP)?

HTG Molecular Diagnostics HTGMQ 12 Shares Outstanding (EOP) is 2.21 Mil as of Mar. 2023. GuruFocus rates HTGMQ with a GF Score™ of 12/100.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. HTG Molecular Diagnostics's shares outstanding for the quarter that ended in Mar. 2023 was 2.21 Mil.

HTG Molecular Diagnostics's quarterly shares outstanding stayed the same from Dec. 2022 (2.21 Mil) to Mar. 2023 (2.21 Mil).

HTG Molecular Diagnostics's annual shares outstanding increased from Dec. 2021 (0.63 Mil) to Dec. 2022 (2.21 Mil). It means HTG Molecular Diagnostics issued new shares from Dec. 2021 to Dec. 2022 .


HTG Molecular Diagnostics  (OTCPK:HTGMQ) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


HTG Molecular Diagnostics Shares Outstanding (EOP) Related Terms


HTG Molecular Diagnostics Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for HTG Molecular Diagnostics's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HTG Molecular Diagnostics Shares Outstanding (EOP) Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.32 0.43 0.63 2.21

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.92 0.92 2.21 2.21

HTGMQ vs ABMC, TMO, DHR: Shares Outstanding (EOP) Comparison

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HTG Molecular Diagnostics Shares Outstanding (EOP) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Shares Outstanding (EOP) falls into.


HTGMQ
12GF Score
HTG Molecular Diagnostics Inc HTGMQ
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HTG Molecular Diagnostics Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 2.21 Mil mean?
HTG Molecular Diagnostics (HTGMQ) has a Shares Outstanding (EOP) of 2.21 Mil as of Mar. 2023. The total shares a company has outstanding, at period-end. View historical data on HTG Molecular Diagnostics and its competitors.
Is HTG Molecular Diagnostics' Shares Outstanding (EOP) too high?
HTG Molecular Diagnostics' current Shares Outstanding (EOP) is 2.21 Mil. Overall, HTG Molecular Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HTG Molecular Diagnostics' Shares Outstanding (EOP) compare to ABMC and TMO?
HTG Molecular Diagnostics' Shares Outstanding (EOP) of 2.21 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Diagnostics & Research company?
A good Shares Outstanding (EOP) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on HTG Molecular Diagnostics and its competitors. HTG Molecular Diagnostics's current Shares Outstanding (EOP) is 2.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HTG Molecular Diagnostics stock overvalued right now?
HTG Molecular Diagnostics (HTGMQ) has a current Shares Outstanding (EOP) of 2.21 Mil. The current Shares Outstanding (EOP) is 2.21 Mil. HTG Molecular Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For HTG Molecular Diagnostics (HTGMQ), the current Shares Outstanding (EOP) is 2.21 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HTG Molecular Diagnostics Business Description

Address 3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
12GF Score

Get the complete analysis for HTGMQ

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price